Next Article in Journal
A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma
Next Article in Special Issue
Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)
Previous Article in Journal
Increased PARP Activity and DNA Damage in NSCLC Patients: The Influence of COPD
Previous Article in Special Issue
Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category
 
 
Article

Article Versions Notes

Cancers 2020, 12(11), 3334; https://doi.org/10.3390/cancers12113334
Action Date Notes Link
article pdf uploaded. 11 November 2020 10:43 CET Version of Record https://www.mdpi.com/2072-6694/12/11/3334/pdf-vor
article supplementary file uploaded. 11 November 2020 10:43 CET - https://www.mdpi.com/2072-6694/12/11/3334#supplementary
article xml file uploaded 13 November 2020 04:23 CET Original file -
article xml uploaded. 13 November 2020 04:23 CET Update https://www.mdpi.com/2072-6694/12/11/3334/xml
article pdf uploaded. 13 November 2020 04:23 CET Updated version of record https://www.mdpi.com/2072-6694/12/11/3334/pdf
article html file updated 13 November 2020 04:24 CET Original file -
article html file updated 23 July 2022 00:38 CEST Update https://www.mdpi.com/2072-6694/12/11/3334/html
Back to TopTop